Tim Wood
Super well-being?
Let’s say, schematically, that our human hedonic range stretches from -10 to 0 to +10. Most people have an approximate hedonic set-point a little above or a little below hedonic zero. Tragically, a minority of people and the majority of factory-farmed nonhuman animals spend essentially their whole lives far below hedonic zero. Some people are mercurial, others are more equable, but we are all constrained by the negative-feedback mechanisms of the hedonic treadmill. In future, mastery of our reward circuitry promises e.g. a hedonic +70 to +100 civilisation – transhuman life based entirely on information-sensitive gradients of bliss (
cf.
https://www.gradients.com). Currently, we can only speculate on what guise such superhuman well-being will take, and how it will be encephalised. What will transhumans and posthumans be happy “about”? I don’t know – probably modes of experience that are physiologically inaccessible to today's humans (
cf.
https://www.hedweb.com/quora/2015.html#irreversible). But one of the beauties of hedonic recalibration is that (complications aside) it’s preference-neutral. Who wouldn’t want to wake up in the morning in an
extremely good mood – and with their core values and preference architecture intact? Aristotle’s “eudaimonia” or sensual debauchery? Mill’s “higher pleasures” or earthy delights? You decide. Crudely, everyone’s
potentially a winner with biological-genetic interventions. Compare the zero-sum status-games of Darwinian life. Unlike getting rid of suffering, I don’t think superhappiness is
morally urgent; but post-Darwinian life will be unimaginably sublime.
What about hedonic uplift for existing human and nonhuman animals prior to somatic gene-editing? Well, one attractive option is ACKR3 receptor blockade (
cf.
https://www.nature.com/articles/s41467-020-16664-0), perhaps in conjunction with selective kappa opioid receptor antagonism. Enhancing “natural” endogenous opioid function and raising hedonic set-points is vastly preferable to taking well-known drugs of abuse that typically activate the negative feedback mechanisms of the CNS with a vengeance. An intensive research program is in order. Pitfalls abound.
In the long run, however, life on Earth needs a genetic rewrite. Pharmacological stopgaps aren't the answer.